Published 28 July 2009, doi:10.1136/bmj.b2546
Cite this as: BMJ 2009;339:b2546

Research

Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial

TOMBOLA Group

Correspondence to: J Little, Canada Research Chair in Human Genome Epidemiology, Department of Epidemiology and Community Medicine, University of Ottawa, 451 Smyth Rd, Ottawa, Ontario K1H 8M5, Canada jlittle{at}uottawa.ca

Objectives To examine the effectiveness of cytological surveillance in primary care compared with immediate referral for colposcopic examination in women with low grade abnormal results on cervical cytology tests.

Design Multicentre individually randomised controlled trial.

Setting NHS cervical screening programmes in Grampian, Tayside, and Nottingham.

Participants 4439 women, aged 20-59, with a cytology result showing borderline nuclear abnormalities or mild dyskaryosis, October 1999-October 2002.

Interventions Cytological screening every six months in primary care (n=2223) or referral for colposcopy and related interventions (n=2216). All women were followed for three years, concluding with an exit appointment at which colposcopic examination was undertaken. Colposcopists assessing outcome at this appointment were blinded to randomisation.

Main outcome measures Primary end point: cumulative incidence of cervical intraepithelial neoplasia grade II or more severe disease. Other end points: cervical intraepithelial neoplasia grade III or worse, clinically significant anxiety and depression, other self reported after effects, and rates of non-attendance. Analysis was by intention to treat; all those randomised were included.

Results The cumulative incidence of cervical intraepithelial neoplasia grade II or worse was 79 per 1000 person years in the colposcopy arm and 58 per 1000 person years in the cytological surveillance arm (relative risk 1.37, 95% confidence interval 1.19 to 1.57). This difference was less marked for cervical intraepithelial neoplasia grade III or more severe disease, but the incidence was still higher in the colposcopy arm (relative risk 1.26, 1.04 to 1.53). Among women randomised to immediate colposcopy, 79% (74.9% to 82.5%) of cases of cervical intraepithelial neoplasia grade II or worse were diagnosed at the time of the immediate colposcopy, while among women randomised to cytological surveillance, 77% (72.1% to 81.2%) of cases were detected by surveillance cytology and related interventions. Similar proportions of women were anxious or depressed in the two arms. A higher proportion of women in the colposcopy arm reported after effects, and these were of longer duration and more severe. Non-attendance was low in both arms.

Conclusion The more marked difference between the arms in the occurrence of cervical intraepithelial neoplasia grade II or worse than in the occurrence of grade III or worse can probably be accounted for by the spontaneous regression of some cases of grade II neoplasia. Compared with cytological surveillance, a policy of immediate colposcopy detects more cervical intraepithelial neoplasia grade II or worse, and some more grade III or worse, but might lead to overtreatment. Such a policy is associated with a higher rate of reported after effects, which are more severe and of longer duration than those associated with cytological surveillance.

Trial registration ISRCTN 34841617.

© 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

An embarrassment of riches
Trish Groves
BMJ 2009 339: b3186. [Extract] [Full Text]

Managing low grade and borderline cervical abnormalities
Eduardo L Franco
BMJ 2009 339: b3014. [Extract] [Full Text]

Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study
Sue Moss, Alastair Gray, Rosa Legood, Martin Vessey, Julietta Patnick, Henry Kitchener Liquid Based Cytology/Human Papillomavirus Cervical Pilot Studies Group
BMJ 2006 332: 83-85. [Abstract] [Full Text] [PDF]

Cervical screening
Angela E Raffle
BMJ 2004 328: 1272-1273. [Extract] [Full Text] [PDF]

Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented
A E Raffle, B Alden, M Quinn, P J Babb, and M T Brett
BMJ 2003 326: 901. [Abstract] [Full Text] [PDF]

Management of women with mild and moderate cervical dyskaryosis
G Flannelly, D Anderson, H C Kitchener, E M F Mann, M Campbell, P Fisher, F Walker, and A A Templeton
BMJ 1994 308: 1399-1403. [Abstract] [Full Text]

This article has been cited by other articles:

  • Franco, E. L (2009). Managing low grade and borderline cervical abnormalities. BMJ 339: b3014-b3014 [Full text]  

Rapid Responses:

Read all Rapid Responses

Invasive disease is what matters
William P Soutter
bmj.com, 24 Aug 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ